Eliquis (Apixaban) receives formal EU approval for marketing: http://finance.yahoo.com/news/ELIQUIS-apixaban-Approved-In-bw-2785334351.html?x=0&.v=1 This is a rubber-stamping of the CHMP’s decision two months ago (#msg-61113322). What about the US market? BMY/PFE have not sounded confident about making headway with the FDA for Eliquis in VTE prevention (#msg-58061618).